Livie Smart, a bone marrow transplant recipient, is serving as the patient champion for the Festival of Trees, which will ...

In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.

Jaypirca is now approved as 100 miligram and 50 miligram tablets for people with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who have previously been treated with ...

The FDA has granted traditional approval to pirtobrutinib (Jaypirca) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma ...

Cancer patient killed by ‘toxic mold’ while recuperating in Airbnb, family says - Exclusive: ‘The loss of a loved one is a ...

This was not the first presentation on STI-571, but it was the one that would change everything: The New England Journal of ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...

GREENFIELD — Three Greenfield youths — a pair of young brothers and a teenage girl — have been selected to serve as ...

A major breakthrough in the treatment of an aggressive form of leukemia is bringing new hope to patients and it started in ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...